Purpose: Chemical exchange saturation transfer (CEST) MRI for breast lesion characterization is promising. However, artifacts are prone to develop in breast CEST imaging as a result of strong lipid signals. The aims of the study are (i) to develop and validate the CEST-Dixon imaging sequence for simultaneous water-fat separation and B 0 mapping; and (ii) use the CEST-Dixon method to characterize suspicious lesions in patients undergoing percutaneous biopsy. Methods: The gradient-echo multi-echo Dixon acquisition is used to create fat-free CEST and B 0 maps. The sequence has been validated in phantoms and in vivo. Five healthy volunteers and 10 patients were scanned to compare the CEST contrast in three frequency ranges centered at 1, 2, and 3.5 ppm. The correlation between the CEST contrast and pathology markers (tumor type, estrogen receptor (ER) status, and Ki-67) was also investigated by stratifying the patients into ER-negative invasive ductal carcinoma (IDC) (more aggressive), ER-positive IDC (less aggressive), and benign groups.
INTRODUCTION
Magnetic resonance imaging has been adopted as both a screening tool for women at high risk for developing breast cancer and as a diagnostic tool to evaluate the extent of disease in women recently diagnosed with breast cancer (1, 2) . Dynamic contrast-enhanced (DCE) breast MRI provides very high sensitivity but lacks specificity (3) as a result of significant overlap in the enhancement patterns of benign and malignant breast lesions (4) . Multiple noncontrast imaging methods, such as spectroscopy and diffusion-weighted imaging, have been developed and applied to breast MRI to improve specificity and decrease false positive results when used either alone, or in combination with dynamic contrastenhanced MRI (5) .
Recently, chemical exchange saturation transfer (CEST) has been investigated for its feasibility and application in cancer imaging, because it provides information at the molecular level that reflects biochemical composition of tissues (6) . Compared with spectroscopy, CEST has significantly improved sensitivity to certain metabolites and can achieve much higher spatial resolution, which is particularly desirable for clinical applications (6) . Amide proton transfer (APT) neuroimaging, a subtype of CEST imaging, is emerging as a powerful tool in the assessment of brain tumor aggressiveness and treatment response monitoring (7, 8) . Several previous studies in cells, animals, and humans applied CEST to breast malignancies also demonstrated the potential of CEST for tumor detection, characterization, and treatment assessment (9) (10) (11) (12) (13) (14) . Therefore, addition of CEST to current breast imaging protocols may potentially lead to technology with improved specificity and prediction value, while retaining excellent sensitivity.
Most of the reported studies on breast CEST imaging are preclinical or focus on imaging sequence implementation and/or optimization (9, (12) (13) (14) . Only two papers on CEST imaging have incorporated a small number of breast cancer patients (10, 11) . Many questions need to be further investigated with regard to the application of CEST to breast malignancy, including how CEST contrast changes in breast tumors, which CEST frequency range has the highest correlation with malignancy, and what are the major contributors to CEST contrast in malignancy.
One of the largest challenges for successful breast CEST imaging is the presence of a large fat signal. Although the total amount of fat varies in the breast, fibroglandular tissue and fat are interleaved. Fat can confound CEST contrast, complicate Z-spectrum appearance, and potentially lead to lipid artifacts and erroneous CEST effects (15, 16) .
In this study, we discuss a CEST-Dixon method that uses the combination of CEST preparation with multipoint Dixon water-fat separation to obtain water-only CEST images (17, 18) . These water-only images are used to calculate magnetization transfer ratio asymmetry (MTR asym ) maps in three CEST frequency ranges for normal tissues and suspicious lesions. Biopsy results were used as the gold standard for method evaluation. The goal of the study includes three aspects: (i) to implement and validate the CEST-Dixon sequence in human subjects at 3 T for simultaneous water-fat separation and B 0 mapping, (ii) to compare the CEST contrasts in normal breast tissues with that of malignant and benign tissues in three CEST frequency ranges, and (iii) to determine whether the CEST-Dixon method could be used to assess tumor status using several standard biopsy pathology markers (estrogen receptor (ER) and Ki-67 (19)) as reference standards.
METHODS

Phantom
To investigate whether CEST-Dixon introduces additional asymmetries in the Z-spectrum, iopamidol (Isovue-300, Bracco Diagnostics, Milan, Italy) phantoms at pH 6.0, 6.5, 7.0, and 7.5 were prepared and transferred to small vials. A vial containing vegetable oil (Crisco, the J.M. Smucker Co, Orrville, OH, USA) was used as a fat reference. A vial of distilled water was prepared as a control. The vials were held in a plastic container that was filled with tap water to minimize B 0 inhomogeneity.
Subjects
The study was approved by the local institutional review board and performed in accordance with the guidelines. Written consent was obtained from each subject. Five female volunteers without known breast diseases and 10 female patients with suspicious breast lesions for which biopsy was recommended were recruited for the study. The patients were scanned prior to biopsy and the diagnostic "gold standard" was provided via clinical pathology results, which included eight malignancies and two nonmalignant lesions. The confirmed malignancies included six invasive ductal carcinoma (IDC), one IDC and encapsulated papillary carcinoma, and one invasive mucinous carcinoma ( Table 1 ). The nonmalignant lesions included one atypical ductal hyperplasia and one fibroadenoma (Table 1) . Only one lesion was scanned per patient. Patient 7 was excluded from the analysis as a result of observable motion, as the tumor was located close to the chest wall. Patient 8 was excluded from the analysis because of the small size of the lesion (which at the acquired image resolution (2 Â 2 mm 2 ) resulted in partial-volume effects and only few pixels for the region of interest (ROI) analysis). Patient 2 was excluded from the analysis because invasive mucinous carcinoma and IDC are two different tumor types. Thus, the analysis included five healthy volunteers and seven patients with suspicious breast lesions in total. The patients are further stratified into three groups: ER-negative (ERÀ) IDC group (Patients 1 and 3, N ¼ 2), ER-positive (ERþ) IDC group (Patients 4-6, N ¼ 3), and benign group (Patients 9 and 10, N ¼ 2). The ERÀ breast cancer lacks the estrogen receptor that is an index for sensitivity to endocrine treatment and is more aggressive than the ER þ breast cancer (20) .
Magnetic Resonance Imaging
A 3T human scanner (Ingenia, Philips Healthcare, Amsterdam, Netherlands) with dual-channel body coil was used throughout the study. The phantom data were acquired using a 15-channel head-spine coil. The CEST preparation consisted of 10 hyperbolic secant (HS) pulses, each 49.5-ms long, flip angle (FA) of 900
, and with a delay of 0.5 ms between the pulses. The total saturation time was 500 ms and B 1, CW ¼ 1.2 mT. The CEST images were acquired using 2-dimensional 3-point multi-echo Dixon sequence with repetition time (TR)/echo time (TE 1 )/DTE ¼ 4.8/1.33/ 1.1 ms, FA ¼ 45
, and centric k-space ordering. The Dixon acquisition was based on a multishot multi-echo T 1 -weighted turbo field-echo sequence. We chose three echoes (3-point Dixon method, Fig. 1 ), as it is the minimal number of the echoes required to obtain water, fat, and B 0 information. A total of 41 offsets were acquired in the Z-spectrum from À10 ppm to 10 ppm, and one reference image was acquired. The field of view was 220 Â 220 mm 2 with a voxel size of 1.5 Â 1.5 mm 2 and a slice thickness of 8 mm.
The human data were acquired using a 16-channel bilateral breast coil. A 3-dimensional fat-suppressed enhanced T 1 high-resolution isotropic volume excitation (eTHRIVE) sequence with a resolution of 0.6 Â 0.6 Â 1 mm 3 was used for anatomical images. The imaging slice was placed for optimal observation of the fibroglandular tissue and/or the suspicious lesion based on the eTHRIVE images. The CEST preparation and acquisition was the same as the phantom experiment except for the following parameters: TR/TE 1 /DTE ¼ 5.1/ 1.57/1.1 ms, FA ¼ 10 , and 33 offsets were acquired in the Z-spectrum from À6 to 6 ppm. The field of view was varied according to the volunteer size, but the in-plane resolution was fixed at 2 Â 2 mm 2 and the slice thickness was 5 mm. Transverse bilateral images were acquired. The data from the first two patients were acquired with SENSE factor of 4 and multishot factor of 14, and the total scan time was 1 min 10 s. All other volunteer and patient data were acquired without SENSE and using multishot factor of 25 to improve the signal-to-noise ratio, and the total scan time was 2 min 26 s.
Data Analysis
Six types of images were obtained using the Dixon method for each frequency offset: (i) the source images (three images total, one per TE), (ii) the water-only image, (iii) fat-only image, (iv) in-phase image (IP), (v) out-of-phase (OP) image, and (vi) the B 0 map. Standard single-peak lipid Philips reconstruction protocol was used to obtain water-only, fat-only, IP, OP, and B 0 images from the source images.
Phantom Studies
To investigate whether CEST-Dixon introduces additional asymmetries in the Z-spectrum, the MTR asym at 1.8, 4.2, and 5.5 ppm (21) calculated from the CEST images acquired with and without Dixon were compared in the phantom study.
In Vivo Studies
The water-fat separation of the CEST-Dixon method was validated in vivo by comparing the Z-spectra from the CEST images acquired with and without Dixon for pixels of different fat fractions. The second echo source images (TE ¼ 2.43 and 2.67 ms for phantom and in vivo studies, respectively; both are close to IP) were chosen to serve as a standard, non-Dixon CEST images for the comparison. The CEST-Dixon images were the water-only images.
The water-only CEST images were processed on a pixel-by-pixel basis using custom MATLAB (The MathWorks, Natick, MA, USA) routines. Field inhomogeneity was corrected using an averaged B 0 map generated by averaging the Dixon B 0 maps of all frequency offsets. MTR asym was used for CEST signal measurement. For in vivo studies, the MTR asym were averaged in the ROIs and in the three frequency ranges: (i) 0.8-1.2 ppm, (ii) 1.8-2.2 ppm, and (iii) 3.3-3.7 ppm, and denoted hydroxyl, amine, and amide MTR asym , respectively.
Region-of-Interest Placement: Healthy Volunteers
The ROIs of the fibroglandular tissue of the healthy volunteers were made based on the signal intensities of the water-only and fat-only images (10) . First, a threshold was selected to exclude the background noise in both water-only and fat-only images. The two masks were then overlapped to locate the pixels affected by partialvolume effects and with high fat fraction (FF). The fat fraction was calculated pixel-wise based on the wateronly and fat-only images: FF ¼ W/(WþF). The high fat fraction pixels were removed from the mask based on the water-only image. Next, the skin, chest wall, and heart were removed from the mask manually to generate the final mask for the fibroglandular tissues.
Region-of-Interest Placement: Patient Volunteers
The tumor ROIs were drawn manually by a fellowshiptrained breast imaging radiologist with 5 years of experience based on the water-only images while referring to the high-resolution eTHRIVE images. The final tumor and fibroglandular-tissue ROIs were reviewed and approved by the radiologist.
Statistical Analysis
A weighted least-squares linear fit was performed for the correlation between MTR asym and Ki-67 level with the inverse of the square of the standard deviation used as the weighting factor (22) , and a P < 0.05 was considered statistically significant. Figure 2 compares the MTR asym at 1.8, 4.2, and 5.5 ppm of the water and iopamidol phantoms calculated from the images acquired with and without Dixon. The nonDixon and Dixon images refer to the second echo source image and water-only images. As shown in Figure 2 , the MTR asym with and without Dixon are similar for all of the phantoms and frequencies, although Dixon results showed slightly increased effect in the iopamidol solutions (the values are still within the experimental error of each other).
RESULTS
To validate the water-fat separation of the CEST-Dixon method, Figure 3 shows the three types of images obtained from a healthy volunteer: the second echo Figure 3h inset. The pixels were selected from a straight line going from fibroglandular tissue to the fat with an increasing fat fraction along the line. Hence, the water-only pixel was from the fibroglandular tissue, the fat-only pixel was from the fat tissue and the pixels with mixed water-fat signals were selected at the interface of the two tissues. Because the second echo source images (TE ¼ 2.67 ms) were close to the IP images, the water dip in the Z-spectra decreases, whereas the fat dip increases as the fat fraction increases (Figs. 3a-3d) (15) . The corresponding water-only and fatonly Z-spectra are shown in Figures 3e to 3h and Figures 3i to 3l, respectively. It can be seen that the water and fat dips were successfully separated, although some residual fat signals were observed in high fat fraction (Fig. 3g, arrow) . The Z-spectra were not normalized to the reference in this figure to better display the pixels whose signal intensities were close to noise level: fatonly pixel in the water-only images (Fig. 3h) and the water-only pixel in the fat-only images (Fig. 3i) . Figure 4 shows the amide CEST maps with and without Dixon and the corresponding whole fibroglandular tissue ROI averaged Z-spectra and MTR asym of the same healthy volunteer as Figure 3 . Here, the ROI encompassing the whole fibroglandular tissue was generated as described previously and is shown in Figure 4g . The non-Dixon images refer to the second and first echo source images, which are close to the IP (TE ¼ 2.67 ms) and OP (TE ¼ 1.57 ms) images, respectively. The Dixon results shown are the water-only images. As shown in Figure 4a , in non-Dixon image, a large number of pixels in the amide CEST map have negative values caused by the presence of fat (15) . Correspondingly, a fat dip is observed in the Z-spectrum, leading to negative amide MTR asym (Fig. 4b) . Non-Dixon images acquired close to the OP condition lead to curiouslooking Z-spectrum and erroneously high MTR asym (Figs. 4c and 4d) as a result of signal interferences and normalization that was discussed in an earlier publication (15) . At the same time, in the water-only Z-spectrum (Fig. 4e) , the fat dip is removed, producing the amide MTR asym and CEST map (Figs. 4e and 4f) that is essentially free of fat influence. To demonstrate the degree of B 0 inhomogeneity that is obtained in a typical case, Figure 4h shows the average B 0 map obtained in the same healthy volunteer. Large deviations in the homogeneity spanning a range from þ200 to À200 Hz can be observed. Figure 5 shows the representative water-only Dixon hydroxyl CEST maps and ROI-averaged Z-spectra and MTR asym for a healthy volunteer (Figs. 5a and 5b) , an IDC, not otherwise specified ER þ patient (Figs. 5c and 5d), and a triple-negative breast cancer patient (Figs. 5e and 5f). The Z-spectrum and MTR asym of the healthy volunteer was averaged across the fibroglandular tissue of both breasts (Fig. 5b) . The Z-spectra and MTR asym of the patients were averaged in the tumor areas (Figs. 5c and  5e ). The MTR asym in the three CEST frequency ranges of all subjects are summarized in Figure 6 and Supporting Figure S1 . When the malignant lesions are stratified by ER status, it can be seen that the ERÀ IDC group exhibits higher CEST effects in all three frequency ranges than the Table 1 ), and a triple-negative breast cancer patient (e, f: Patient 3 in Table 1 ). Note different y-scale for Z-spectra (blue) and MTR asym (red). The CEST maps in (a), (c), and (e) are overlaid on the reference water-only images. The panels above (a, c, e) show the corresponding ROIs in red: averaged across the fibroglandular tissues of both breasts (b); and averaged in the tumor areas as indicated by the ROIs (d, f) . See "Methods" section for more details on the ROI placement.
ER þ IDC, benign, and normal groups (Fig. 6 ). For the three frequency ranges, the ER þ IDC, benign, and normal groups tend to have similar CEST effects that suggest that the ER þ IDC group is indistinguishable from normal and benign groups. Moreover, the hydroxyl range has the largest difference between the ERÀ IDC and the other groups. Hence, Figure 5 displays hydroxyl MTR asym . When not stratified by ER status, although the IDC group displays higher MTR asym in hydroxyl and amine ranges than the other groups, the deviations across subjects increase (Supporting Fig. S1 ).
In Figure 7 , the tumor MTR asym in the three frequency ranges are plotted against the Ki-67. It can be seen that the MTR asym increases as the Ki-67 level increases for all frequency ranges. The R 2 values were 0.95, 0.87, and 0.36 for hydroxyl, amine, and amide frequency ranges, respectively. Figure 8 displays the MTR asym in the three frequency ranges for all subjects, similar to Figure 6 , but using the second echo source images. The hydroxyl and amine ranges still have the highest values in the ERÀ IDC group; however, the amine MTR asym had decreased in ER þ IDC, benign, and normal groups (Fig. 8 versus Fig.  6 ). This is caused by the influence of the lipid signals on the amine frequencies. Moreover, the APT signal becomes negative for normal, benign, and ER þ lesions, as a result of increased negative lipid contribution.
DISCUSSION
The presence of strong lipid signals is a big challenge for body CEST imaging, because fat can lead to erroneous CEST contrast. The CEST-Dixon method offers an attractive approach around this obstacle. The B 0 maps derived from the Dixon technique can be used for field inhomogeneity correction, without the need for a separate B 0 mapping sequence. In this study, a 3-point multi-echo Dixon is used for image acquisition. Three TE values were chosen because this is the least number of echoes needed to robustly separate water, fat, and B 0 . The DTE was adjusted to the minimum possible value to reduce potential artifacts caused by phase wrapping.
The CEST-Dixon method was validated in phantoms and in vivo. In the phantom experiment, the MTR asym with and without Dixon are similar (Fig. 2) , indicating that the Dixon water-fat decomposition does not introduce additional asymmetries to the Z-spectrum. The vial containing fat only was not visible in the water-only images. Moreover, Figure 2 indicates that MTR asym measurements using Dixon images lead to a slightly reduced standard deviation. This might be the result of the multipoint Dixon postprocessing involving three echoes acting similar to averaging, thus increasing the signal-to-noise ratio.
The in vivo results of the healthy volunteers show successful water-fat separation (Figs. 3m to 3o) . However, in some of the pixels with high fat fraction (approximately > 50%), the lipid peak was still detectable in the water-only images (Fig. 3g, arrow) , albeit much smaller than what is observed in the non-Dixon image (compare Figs. 3c versus 3g) . This residual fat contribution in the Z-spectrum would be magnified by normalization (15) ; hence, MTR asym distortions might still be observed. For this reason, in this preliminary study, the pixels with high fat fraction were removed from the ROIs to avoid the influence of the residual fat. Although we cannot conclusively indicate the origin of this residual artifact, partial-volume effects might be a contributing factor (10) . Another factor should also be considered: the fat-water separation model of multipoint Dixon postprocessing assumes nonsaturated water and fat peaks, which is not true in CEST. In addition, as the single-peak model for fat was used in the image reconstruction, other fat peaks would remain in the Z-spectrum and introduce additional asymmetries. Especially the second and third largest fat peaks, which lie approximately 3.8 ppm upfield and 0.6 ppm downfield, respectively, may influence the amide and hydroxyl MTR asym accordingly. Additional investigation is needed on the influence of the saturation and multipeak versus single-peak modeling on CESTDixon method. Finally, it might be a contribution from the true relayed nuclear Overhauser effect, cleared from the artifact contribution of the saturated, but nonexchanging lipids.
Figures 4e and 4f demonstrate that despite some residual problems described above, CEST-Dixon leads to a smoother Z-spectrum in the normal fibroglandular tissue, and although residual lipid artifacts might be observable in some pixels, overall their influence is removed. Moreover, the Z-spectrum from water-only images displays higher suppression levels near water resonance (almost zero) as expected (Fig. 4f) , while the second echo (close to IP) leads to higher values close to water resonance because of the fat signal contribution (Fig. 4a) .
Following validation of the CEST-Dixon method in the healthy volunteers, a preliminary study was conducted in the small group of patients with suspicious breast lesions identified at mammography and ultrasound. Figures 5 and 6 and Supporting Figure S1 demonstrate that the MTR asym in the healthy fibroglandular tissue is generally low, approximately 2% for all three frequency ranges. Comparing the previously reported human breast studies at 3 T, the amide MTR asym is slightly lower than the previously reported values (10,14) ; however, MTR asym at 1.2, 1.3, and 1.8 ppm reported previously was mostly negative (11) , presumably the result of lipid contribution. The standard deviations within the ROI that included whole fibroglandular tissue (with high fat fraction pixels excluded) were approximately 4% (with minimum 2% and maximum 5% observed). This relatively large standard deviation is in line with previous CEST measurements in breast at 3 T and at 7 T (10,13,14) . Table 1 lists MTR asym values measured in the patients. The standard deviations with ROIs are similar to the ones observed in healthy volunteers. The data were stratified by ER status (ERÀ versus ERþ). Figure 6 suggests that such stratification provides differentiation between the more aggressive and less aggressive cancer groups. In ERÀ IDC tissues, there is a trend toward increased MTR asym compared with the ER þ IDC, benign, and normal tissues-especially in the hydroxyl and amine ranges (Fig.  6) . The ER þ IDC and benign lesions demonstrate MTR asym values close to normal fibroglandular tissue in all three frequency ranges. When both ER statuses are grouped together, the trend of increased MTR asym in the IDC group, as compared with the other groups, can still be seen in the hydroxyl and amine ranges, however this trend is reduced (Supporting Fig. S1 ). In the amide range, the IDC group becomes indistinguishable from the benign and normal groups (Supporting Fig. S1 ). Although the sample sizes are very small, these preliminary data re-iterate the important potential for CEST MRI to differentiate more aggressive from less aggressive breast cancers.
A statistically significant correlation was observed between Ki-67 and MTR asym in all three frequency ranges, with the most significant correlation for hydroxyl MTR asym and amine MTR asym close behind (Fig. 7) . Our study is small and the Ki-67 values reported here do cluster at the low and high end. Nevertheless, to the best of our knowledge, correlation of Ki-67 and APT was observed previously in the animal model of brain cancer (23), but our results are the first to demonstrate such correlation in humans. High Ki-67 indicates increased cell proliferation. Although it is not an accepted marker of breast cancer aggressiveness, it is one of the standard pathological indices evaluated for patient care and is associated with more aggressive cancer types (24) . The observed correlation is in agreement with our previous observations, indicating a trend to increased CEST contrast in more aggressive tumors. Although larger studies are needed to validate this result, it indicates the potential of CEST MRI to provide important information on the molecular level that could complement and improve specificity of current breast MRI protocols.
Following stratification by subtypes, the largest MTR asym values were observed in hydroxyl and amine ranges. Moreover, the largest difference among ERÀ IDC versus ER þ IDC, benign, and normal values was observed in hydroxyl MTR asym (Fig. 6) , and the strongest correlation with Ki-67 was also observed in hydroxyl and amine ranges (Fig. 7) . Previous studies did not differentiate by tumor types, but Ref. (11) also demonstrated increased hydroxyl MTR asym in malignancy, in general agreement with our observations (Supporting Fig. S1 ). Moreover, the focus on hydroxyl and amine range is in agreement with recent studies in cells and animal models that also focused on the hydroxyl MTR asym (9, 12) . The origins of the increased CEST contrast in the hydroxyl range (or in 1.2 to 1.8 ppm range as in (11)) were attributed to the increase in the glycosaminoglycan concentration (13) , alterations in mucin (12) , or products of choline metabolism (9, 11, 25) . Moreover, our observations appear to suggest an increase in hydroxyl MTR asym associated with more aggressive metabolism as indicated by ER status and Ki-67 (Figs. 6 and 7 ). This deviates from the animal model observations, in which a decrease in hydroxyl MTR asym was associated with more aggressive cancers (9, 12) . At the same time, the very large hydroxyl MTR asym (13.6%) observed in the mucinous carcinoma case (Patient 2, Table 1 ) supports the sensitivity of CEST MRI to mucin concentration as suggested previously (12) . More studies are required, in cells, animal models and humans, to address the origins of the CEST changes in breast malignancy. Figures 6 and 7 suggest that APT signal, which was proven to be the best for monitoring of brain malignancies (26) , might be less suitable for the monitoring of malignant alterations in breast. It should be noted that the purpose of this study was not to fully address these important questions, but to provide a new tool for the assessment of breast malignancy at 3 T. In this preliminary study, statistical analyses were not performed for Figures 6, 8 , and Supporting Figure S1 because of the small number of subjects. In Figures 6  and 8 , the number of each group is further reduced when the tumors are stratified by ER status. However, the results do reflect the trend of change in the CEST contrast, indicating the potential of CEST imaging in tumor characterization. Currently, a study using improved breast CEST imaging protocol on more subjects is ongoing. Figure 8 is analogous to Figure 6 , but using nonDixon, second echo source images. The influence of fat on the APT signals in normal, and benign and ER þ IDC groups is obvious, with the signals becoming negative. The standard deviations also increase in all three frequency ranges. Figure 6 clearly demonstrates the importance of the efficient water-fat separation in the breast CEST studies and advantage of Dixon method in conjunction with CEST.
Application of multi-echo acquisition and Dixon postprocessing has another advantage, even in the areas void of fat: It provides an embedded B 0 map acquired at the same time as CEST. Careful B 0 correction is essential for accurate CEST mapping, especially at the lower 3T field and for resonances close to water (i.e., hydroxyl). Great effort is dedicated to careful B 0 mapping; however, there are unavoidable uncertainties when a separate B 0 map is acquired (using gradient echoes or WASSR (27) ), associated with the subject's motion between scans and changes in hardware temperature and water frequency drift. The Dixon method used here eliminated many of the uncertainties and provided perfectly registered, dynamically updated B 0 maps.
Because all of the echoes are acquired in the same shot (Fig. 1) , use of the multi-echo Dixon method does not add to the total scan time. Our implementation took approximately 2.5 min, equivalent to the acquisition time of a standard gradient-echo sequence. Moreover, some time was saved by not acquiring a separate B 0 map, which typically takes approximately 30 s. Although motion was not a problem in most of the cases, it could be a problem for lesions close to the chest wall, as was the case for Patient 7 (Table 1 ). In such cases, breathingsynchronization strategies and motion postprocessing could be used (28) .
Fat suppression in breast imaging can be challenging (29) . First, B 0 inhomogeneity is large, deteriorating the efficacy of the spectral-selective pulses used in selective fat suppression and spectral presaturation with inversion recovery (SPIR) methods. Second, B 1 inhomogeneity creates challenges for inversion pulses (such as in SPIR and short tau inversion recovery (STIR)). Finally, the fat signal consisted of multiple fat components with different T 1 s, challenging the SPIR and STIR implementation. In comparison, the Dixon method is insensitive to B 0 and B 1 inhomogeneities (30, 31) . Moreover, the combination of CEST with Dixon avoids interferences of the preparation pulses (and their imperfections) with the CEST saturation train, and does not add to the total specific absorption rate, which could already be high. Thus, there are numerous potential advantages to using Dixon methods with CEST in breast.
Here, we used the simplest MTR asym analysis. Another alternative to fat suppression could be advanced postprocessing using multi-Lorentzian (32) or other model-based fittings. Such methods could offer the advantage of quantitative information on different exchanging moieties. However, IP images have to be acquired to ease the fitting; or the influence of the echo timings (15) should be included in the fitting model. Moreover, multiLorentzian fitting is model-and pool number-dependent and require sophisticated offline postprocessing. In contrast, all human commercial scanners have at least a three-echo version of the Dixon acquisition and postprocessing implemented (such as the one used here). It is also tempting to speculate that the sequence could be used to differentiate lipid artifact stemming from saturation of nonexchanging fat from relayed nuclear Overhauser effect occurring via dipolar interaction and exchange with water molecules (33) .
Small lesions could still be challenging to detect and analyze, as was the case with Patient 8. The partialvolume effects pose the same problem for all imaging methods used in breast, independent of what fat suppression method is used.
Finally, a technical limitation of this study should be noted. We have used a bilateral imaging protocol, although unilateral may provide better B 1 homogeneity. Also, in this preliminary study we have chosen a B 1 field of 1.2 mT. This value was selected based on a rough optimization in two patients, previous brain studies, and reports of breast studies in literature (10) . Optimal B 1 value depends on the exchange rate, and therefore may depend on which group is chosen for observation. Previous human studies had focused on APT (10, 14) , although cell and animal studies indicated higher dependence on hydroxyl protons (9, 12) , as discussed previously. Our preliminary results also indicated increased differences in hydroxyl region. Thus, we decided to use lower power and a more selective pulse. Moreover, total saturation length was 500 ms, which is the longest allowed in standard RF amplifier operating mode. However, it is known that longer RF saturation leads to an improved CEST effect. Based on the preliminary results presented here, we can conclude that hydroxyl range shows promise to be most sensitive to the important malignant alterations. Thus, we are conducting further optimization of the saturation protocol, in terms of length and RF power, using alternating transmit to achieve prolong saturation (34) (> 500 ms) and using unilateral imaging.
CONCLUSIONS
In the present study, the CEST-Dixon method was shown to be promising for CEST MRI in breast at 3 T. Water-fat decomposition leads to homogenous fat removal in the water-only images. The more aggressive ERÀ IDC malignancy displays a trend to higher CEST contrast than the less aggressive ER þ IDC, benign, and normal tissues. No significant differences were observed among the ER þ IDC, benign, and normal groups. Significant correlation between MTR asym and Ki-67 was observed. The hydroxyl range demonstrated the highest correlation with malignant alteration in breast, in agreement with previous cell, animal, and human studies. Although the study is preliminary, the results indicate that the CEST imaging using Dixon for water-fat separation may differentiate between more aggressive and less aggressive breast cancer. A larger clinical study is needed to fully validate these observations and investigate the added value of CEST-Dixon in breast MRI imaging.
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